FindMyKOL
Clinical trialNCT06479382CompletedInterventional

Study of the ETX-4143 2.0 Device in Subjects With Eye Pain

SponsorEyeCool Therapeutics, Inc.Enrollment31Eye Pain
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A prospective early-feasibility study to evaluate the safety and effectiveness of the ETX-4143 2.0 device. The device is intended to treat subjects with eye pain

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Ophthamic Trials Australia

    Brisbane, Queensland, Australia

  • Innovative Eye Care

    Adelaide, South Australia, Australia

  • Sunshine Eye Surgeons

    St Albans, Victoria, Australia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Aug 2024
Primary completion
29 Nov 2024
Completion
29 Nov 2024
Last update posted
22 Aug 2025
Registered enrollment
31
Registry id
NCT06479382

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.